Robotic surgery for bladder cancer speeds recovery, reduces pain, and improves quality of life. It also significantly reduces risks such as blood clots and can preserve functions like sexual health.
For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment ...
The Bladder Cancer Treatment Market was valued at USD 5.13 Billion in 2025 and is projected to expand at a 9.2% CAGR from ...
Surgery hasnt always been an option for metastatic bladder cancer (or bladder cancer thats spread from its original site). But according to limited research, surgical treatments may now help some ...
Enfortumab vedotin plus pembrolizumab significantly improves EFS and OS in cisplatin-ineligible MIBC patients, offering a new treatment option. The EV-303 trial is the first to show systemic treatment ...
AstraZeneca (AZN) said Friday the US Food and Drug Administration granted priority review to its application for an Imfinzi combination therapy to treat muscle-invasive bladder ca ...
The US regulatory agency has just started a priority review of Imfinzi (durvalumab), in combination with Pfizer and ...
US FDA accepts and grants priority review status to AstraZeneca’s sBLA for Imfinzi plus neoadjuvant enfortumab vedotin to treat patients with muscle-invasive bladder cancer: Cam ...